Spontaneous bacterial peritonitis: Difference between revisions
Jump to navigation
Jump to search
imported>Robert Badgett No edit summary |
imported>Robert Badgett |
||
| Line 26: | Line 26: | ||
===Oral treatment=== | ===Oral treatment=== | ||
{| class="wikitable" | {| class="wikitable" | ||
|+ [[Randomized controlled trial]]s of oral antibiotics for | |+ [[Randomized controlled trial]]s of oral antibiotics for spontaneous bacterial peritonitis<ref name="pmid14571754">{{cite journal| author=Tuncer I, Topcu N, Durmus A, Turkdogan MK| title=Oral ciprofloxacin versus intravenous cefotaxime and ceftriaxone in the treatment of spontaneous bacterial peritonitis. | journal=Hepatogastroenterology | year= 2003 Sep-Oct | volume= 50 | issue= 53 | pages= 1426-30 | pmid=14571754 | ||
| url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&retmode=ref&cmd=prlinks&id=14571754 }} <!--Formatted by http://sumsearch.uthscsa.edu/cite/--></ref><ref name="pmid10782908">{{cite journal| author=Ricart E, Soriano G, Novella MT, Ortiz J, Sàbat M, Kolle L et al.| title=Amoxicillin-clavulanic acid versus cefotaxime in the therapy of bacterial infections in cirrhotic patients. | journal=J Hepatol | year= 2000 | volume= 32 | issue= 4 | pages= 596-602 | pmid=10782908 |doi=10.1016/S0168-8278(00)80221-4 | | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&retmode=ref&cmd=prlinks&id=14571754 }} <!--Formatted by http://sumsearch.uthscsa.edu/cite/--></ref><ref name="pmid10782908">{{cite journal| author=Ricart E, Soriano G, Novella MT, Ortiz J, Sàbat M, Kolle L et al.| title=Amoxicillin-clavulanic acid versus cefotaxime in the therapy of bacterial infections in cirrhotic patients. | journal=J Hepatol | year= 2000 | volume= 32 | issue= 4 | pages= 596-602 | pmid=10782908 |doi=10.1016/S0168-8278(00)80221-4 | ||
| url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&retmode=ref&cmd=prlinks&id=10782908 }} <!--Formatted by http://sumsearch.uthscsa.edu/cite/--></ref><ref name="pmid11059861">{{cite journal| author=Terg R, Cobas S, Fassio E, Landeira G, Ríos B, Vasen W et al.| title=Oral ciprofloxacin after a short course of intravenous ciprofloxacin in the treatment of spontaneous bacterial peritonitis: results of a multicenter, randomized study. | journal=J Hepatol | year= 2000 | volume= 33 | issue= 4 | pages= 564-9 | pmid=11059861 | | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&retmode=ref&cmd=prlinks&id=10782908 }} <!--Formatted by http://sumsearch.uthscsa.edu/cite/--></ref><ref name="pmid11059861">{{cite journal| author=Terg R, Cobas S, Fassio E, Landeira G, Ríos B, Vasen W et al.| title=Oral ciprofloxacin after a short course of intravenous ciprofloxacin in the treatment of spontaneous bacterial peritonitis: results of a multicenter, randomized study. | journal=J Hepatol | year= 2000 | volume= 33 | issue= 4 | pages= 564-9 | pmid=11059861 | ||
| Line 33: | Line 33: | ||
|- | |- | ||
! Intervention!!Control | ! Intervention!!Control | ||
<!-- | |||
This is not a study of PO versus IV but is a study of IV->PO moxifloxacin versus IV->PO amoxicillin-clavulanic acid | |||
|- | |- | ||
| Grange<ref name="grange2004"/><br/>2004|| 35 patients|| moxifloxacin versus amoxicillin-clavulanic acid|| | | Grange<ref name="grange2004">Grange J. Randomized, comparative study of moxifloxacin versus amoxicillin-clavulanate in the treatment of bacterial infections in cirrhotic patients. Hepatology 2004;40(4 (Suppl 1)):631A.</ref><br/>2004|| 35 patients|| moxifloxacin versus amoxicillin-clavulanic acid|| SBP resolution|| 94%|| 100% | ||
--> | |||
|- | |- | ||
| Tuncer<ref name="pmid14571754"/><br/>2003 ||53 patients|| | | Tuncer<ref name="pmid14571754"/><br/>2003 ||53 patients|| Oral ciprofloxacin versus one of two IV third-generation cephalosporins||SBP resolution|| 84%|| 76% and 83% | ||
|- | |- | ||
| Ricart<ref name="pmid10782908"/><br/>2000|| 48 patients|| | | Ricart<ref name="pmid10782908"/><br/>2000|| 48 patients|| Oral amoxicillin-clavulanic acid for an average of 2.6 days then orallly for an average of 5.6 days versus cefotaxime IV for an average of 8 days|| Hospital survival|| 90%|| 83% | ||
|- | |- | ||
| Terg<ref name="pmid11059861"/><br/>1997|| 80 patients|| ciprofloxacin IV for two | | Terg<ref name="pmid11059861"/><br/>1997|| 80 patients. No exclusion criteria|| Oral ciprofloxacin for five days after IV for two days versus ciprofloxacin IV for seven days|| Hospital survival|| 77.5%|| 77.5% | ||
|- | |- | ||
| Figueiredo<ref name="Figueiredo1997"/><br/>1996|| 38 patients|| | | Figueiredo<ref name="Figueiredo1997"/><br/>1996|| 38 patients||Oral cefixime versus IV ceftriaxone|| Survival after two days of stopping antibiotics|| 80%|| 83% | ||
|- | |- | ||
| Navasa<ref name="navasa1996"/><br/>1996 || 123 patients|| | | Navasa<ref name="navasa1996"/><br/>1996 || 123 patients. Excluded septic shock, grade II-IV hepatic encephalopathy, serum creatinine level of > 3 mg/dL, and gastrointestinal hemorrhage or ileus|| Oral ofloxacin versus IV cefotaxime||Hospital survival|| 100%|| 100% | ||
|} | |} | ||
==References== | ==References== | ||
<references/> | <references/> | ||
Revision as of 10:42, 6 September 2009
In medicine, spontaneous bacterial peritonitis (SB) is a form of peritonitis that occurs in patient with ascites.[1] Monomicrobial nonneutrocytic bacterascites is a positive culture for a pure growth of a single type of organism but the neutrophil count is less than 250 cells/mm3.[2] About a third of patients with monomicrobial nonneutrocytic bacterascites will progress to SBP.[2]
Etiology/cause
Proton pump inhibitors may be associated with SBP.[3]
Diagnosis
On physical examination, most patients have mild abdominal pain.[4]
The impression of the physician performing the physical examination may not be accurate:[4]
- sensitivity = 76%
- specificity = 34%
Regarding individual signs and symptoms:
- Fever over 100.4°on physical examination
- sensitivity = 18%
- specificity = 90%
- "Any abdominal pain or tenderness" on physical examination
- sensitivity = 94%
- specificity = 15%
Treatment
The role of antibiotics is not clear as "oral quinolones could be considered an option for those with less severe manifestations".[5]
Oral treatment
| Trial | Patients | Comparison | Outcome | Results | |
|---|---|---|---|---|---|
| Intervention | Control | ||||
| Tuncer[6] 2003 |
53 patients | Oral ciprofloxacin versus one of two IV third-generation cephalosporins | SBP resolution | 84% | 76% and 83% |
| Ricart[7] 2000 |
48 patients | Oral amoxicillin-clavulanic acid for an average of 2.6 days then orallly for an average of 5.6 days versus cefotaxime IV for an average of 8 days | Hospital survival | 90% | 83% |
| Terg[8] 1997 |
80 patients. No exclusion criteria | Oral ciprofloxacin for five days after IV for two days versus ciprofloxacin IV for seven days | Hospital survival | 77.5% | 77.5% |
| Figueiredo[9] 1996 |
38 patients | Oral cefixime versus IV ceftriaxone | Survival after two days of stopping antibiotics | 80% | 83% |
| Navasa[10] 1996 |
123 patients. Excluded septic shock, grade II-IV hepatic encephalopathy, serum creatinine level of > 3 mg/dL, and gastrointestinal hemorrhage or ileus | Oral ofloxacin versus IV cefotaxime | Hospital survival | 100% | 100% |
References
- ↑ ICD9: 567.23
- ↑ 2.0 2.1 Runyon BA (1990). "Monomicrobial nonneutrocytic bacterascites: a variant of spontaneous bacterial peritonitis.". Hepatology 12 (4 Pt 1): 710-5. PMID 2210672.
- ↑ Bajaj JS, Zadvornova Y, Heuman DM, et al. (May 2009). "Association of proton pump inhibitor therapy with spontaneous bacterial peritonitis in cirrhotic patients with ascites". Am. J. Gastroenterol. 104 (5): 1130–4. DOI:10.1038/ajg.2009.80. PMID 19337238. Research Blogging.
- ↑ 4.0 4.1 Chinnock B, Afarian H, Minnigan H, Butler J, Hendey GW (September 2008). "Physician clinical impression does not rule out spontaneous bacterial peritonitis in patients undergoing emergency department paracentesis". Ann Emerg Med 52 (3): 268–73. DOI:10.1016/j.annemergmed.2008.02.016. PMID 18433932. Research Blogging.
- ↑ Chavez-Tapia NC, Soares-Weiser K, Brezis M, Leibovici L (2009). "Antibiotics for spontaneous bacterial peritonitis in cirrhotic patients". Cochrane Database Syst Rev (1): CD002232. DOI:10.1002/14651858.CD002232.pub2. PMID 19160207. Research Blogging.
- ↑ 6.0 6.1 Tuncer I, Topcu N, Durmus A, Turkdogan MK (2003 Sep-Oct). "Oral ciprofloxacin versus intravenous cefotaxime and ceftriaxone in the treatment of spontaneous bacterial peritonitis.". Hepatogastroenterology 50 (53): 1426-30. PMID 14571754.
- ↑ 7.0 7.1 Ricart E, Soriano G, Novella MT, Ortiz J, Sàbat M, Kolle L et al. (2000). "Amoxicillin-clavulanic acid versus cefotaxime in the therapy of bacterial infections in cirrhotic patients.". J Hepatol 32 (4): 596-602. DOI:10.1016/S0168-8278(00)80221-4. PMID 10782908. Research Blogging.
- ↑ 8.0 8.1 Terg R, Cobas S, Fassio E, Landeira G, Ríos B, Vasen W et al. (2000). "Oral ciprofloxacin after a short course of intravenous ciprofloxacin in the treatment of spontaneous bacterial peritonitis: results of a multicenter, randomized study.". J Hepatol 33 (4): 564-9. PMID 11059861.
- ↑ 9.0 9.1 Figueiredo FAF, Coelho HSM, Soares JAS, Salgueiro E, Pinto CA. Oral cephalosporin for the treatment of non-severe spontaneous bacterial peritonitis in liver disease: a prospective study of 38 cases [Cefalosporina oral para o tratamento da peritonite bacteriana espontanea nao complicada na cirrose hepatica: um estudo prospectivo de 38 casos]. GED - Gastrenterologia-Endoscopia-Digestiva 1997;16(6):231-6.